Cargando…
Use of buprenorphine for those with employer-sponsored insurance during the initial phase of the COVID-19 pandemic
OBJECTIVE: To quantify weekly rates of use of buprenorphine for those with employer-based insurance and whether the rate differs based on county-level measures of race, historical fatal drug overdose rate, and COVID-19 case rate. METHODS: We used 2020 pharmaceutical claims for 4.8 million adults fro...
Autores principales: | Cantor, Jonathan, Dick, Andrew W., Haffajee, Rebecca, Pera, Megan F., Bravata, Dena M., Stein, Bradley D., Whaley, Christopher M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546915/ https://www.ncbi.nlm.nih.gov/pubmed/34080552 http://dx.doi.org/10.1016/j.jsat.2021.108384 |
Ejemplares similares
-
Costs of Specialist Referrals From Employer-Sponsored Integrated Health Care Clinics Are Lower Than Those From Community Providers
por: Wright, John R., et al.
Publicado: (2022) -
Mental Health Service Utilization Rates Among Commercially Insured Adults in the US During the First Year of the COVID-19 Pandemic
por: McBain, Ryan K., et al.
Publicado: (2023) -
Industry Variation in Risk of Delaying Care During COVID-19
por: Whaley, Christopher M., et al.
Publicado: (2021) -
The impact of the COVID-19 pandemic and policy response on health care utilization: Evidence from county-level medical claims and cellphone data()
por: Cantor, Jonathan, et al.
Publicado: (2022) -
Changes in Health Services Use Among Commercially Insured US Populations During the COVID-19 Pandemic
por: Whaley, Christopher M., et al.
Publicado: (2020)